Gut microbial metabolite TMAO increases peritoneal inflammation and peritonitis risk in peritoneal dialysis patients.

MLA

Zhang, Lei, et al. “Gut Microbial Metabolite TMAO Increases Peritoneal Inflammation and Peritonitis Risk in Peritoneal Dialysis Patients.” Translational Research : The Journal of Laboratory and Clinical Medicine, vol. 240, Feb. 2022, pp. 50–63. EBSCOhost, https://doi.org/10.1016/j.trsl.2021.10.001.

APA

Zhang, L., Xie, F., Tang, H., Zhang, X., Hu, J., Zhong, X., Gong, N., Lai, Y., Zhou, M., Tian, J., Zhou, Z., Xie, L., Hu, Z., Zhu, F., Jiang, J., & Nie, J. (2022). Gut microbial metabolite TMAO increases peritoneal inflammation and peritonitis risk in peritoneal dialysis patients. Translational Research : The Journal of Laboratory and Clinical Medicine, 240, 50–63. https://doi.org/10.1016/j.trsl.2021.10.001

Chicago

Zhang, Lei, Feifei Xie, Haie Tang, Xinrong Zhang, Jianxia Hu, Xiaohong Zhong, Nirong Gong, et al. 2022. “Gut Microbial Metabolite TMAO Increases Peritoneal Inflammation and Peritonitis Risk in Peritoneal Dialysis Patients.” Translational Research : The Journal of Laboratory and Clinical Medicine 240 (February): 50–63. doi:10.1016/j.trsl.2021.10.001.